Eltrombopag Suppliers & Bulk Manufacturers
Available Forms: Tablets & Oral suspension
Available Strengths: Tablet: 25 mg, 50 mg, 75 mg; Suspension: 12.5 mg/5 mL
Reference Brands: Promacta® (US & EU); Revolade®(EU)
Category: Hepatitis
Eltrombopag is available in Tablets & Oral suspension and strengths such as Tablet: 25 mg, 50 mg, 75 mg; Suspension: 12.5 mg/5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Eltrombopag is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Eltrombopag can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Eltrombopag Tablets (Promacta® / Revolade® generic) are thrombopoietin receptor agonists indicated for chronic ITP, severe aplastic anemia, and HCV-related thrombocytopenia. Available in 25 mg, 50 mg, and 75 mg oral tablet strengths, the product is manufactured under EU-GMP and USFDA-compliant facilities. Offered for B2B supply, hospital tenders, and licensing deals, with full CTD dossiers, bioequivalence studies, and regulatory support. Eltrombopag is a key addition for companies supplying hematology and oncology portfolios in regulated and semi-regulated markets, supporting global access to thrombopoiesis-stimulating therapies.
Frequently Asked Questions
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength: Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View Details
Glecaprevir/Pibrentasvir
Strength: Glecaprevir 100 mg Pibrentasvir 40 mg
Form: Oral tablets
Reference Brands: Mavyret®
View Details
Ribavirin
Strength: Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View Details
Adefovir Dipivoxil
Strength: 10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers